Radiopharm Theranostics Limited
RADX
Last
$1.13
Day
+1.8%
1y
-81.7%
5y
-93.7%
52w
-93.2%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
1.54
EMA 50
2.12
EMA 200
3.74
20d high
-46.5%
5y high
-97.8%
5y range
0th
Positions held
Your positionsRADX isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.46
Stop
$0.82
Stop distance
27.4%
Target vs last
+29.2%
Fundamentals
| Market cap | $16.20M | Enterprise value | $9.55M | Trailing P/E | — | Forward P/E | -0.48 |
| PEG | — | Price / book | 0.73 | Beta | 0.86 | Dividend yield | 0.00% |
| Revenue growth | -36.9% | Earnings growth | — | Gross margin | -2.7% | Operating margin | -4.0% |
| Profit margin | 0.0% | ROE | -1.7% | ROA | -45.2% | Debt / equity | — |
| Current ratio | 1.16 | Free cash flow | -$31.14M | Analyst recommendation | strong_buy | Mean target | $17.03 |
| 52w high | $16.25 | 52w low | $1.00 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $3.6M | $0.3M | $0.3M | $0.0M |
| Op margin | -953.4% | -12423.3% | -10839.6% | -225527.7% |
| Net income | -$38.3M | -$47.9M | -$34.6M | -$30.3M |
| Gross margin | 1.1% | 100.0% | 100.0% | 100.0% |
| Gross profit | $0.0M | $0.3M | $0.3M | $0.0M |
| Operating income | -$34.6M | -$37.2M | -$31.7M | -$19.9M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsRADX · daily-32.7% over 13 sessions
Close EMA21 EMA50 EMA200